Fiche centre
CHU de Strasbourg
Strasbourg — France
Essais liés4clinical trials
VilleStrasbourglocalisation
PaysFrancelocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT01521988
Essais cliniques associés
4| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| RCHOP21 | SEP | Phase 3 | NCT01285765 | Evaluate a Treatment Adapted to the PET Response Compared to a Standard Treatment, for Low Risk DLBCL CD 20+ Patients | COMPLETED |
| Atrial flutter ablation | Maladie coronarienne | Non applicable | NCT01521988 | PAF CRIOBLAF — Cryoballoon Pulmonary Venous Isolation in Patients Referred for Typical Atrial Flutter Ablation | COMPLETED |
| Ocrelizumab Injection [Ocrevus] | SEP | Phase 3 | NCT05999604 | WINDOCRE — Impact of Annual Versus Biannual Infusions of Ocrelizumab in Patients With Active MS,After 2 Years of Initial Treatment, on Freedom From Radiological Disease Activity at Two Years: a Multicenter Randomized Controlled Non-inferiority Trial | ACTIVE_NOT_RECRUITING |
| Teriflunomide | SEP | Phase 3 | NCT02587195 | TERICIS — A Study to Evaluate the Safety of Long Term Treatment With Teriflunomide 14 mg Once Daily in Patients With a First Clinical Episode Suggestive of Multiple Sclerosis in a Long-term Extension Period | COMPLETED |